Mineralys Therapeutics Earnings
NASDAQ: MLYSHealthcareBiotechnologyUSD
23.37+0.99 (+4.42%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Mineralys Therapeutics earnings summary
In its most recent report on Aug 11, 2026 (Q2 2026), MLYS posted EPS of $-2.85. Across the last 14 reports, MLYS shares moved an average of 5.9% (in either direction) in the first trading session after results, rising 8 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
MLYS earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 11, 2026 | — | $-2.85 | — | +0.0% |
| May 6, 2026 | — | $-0.47 | — | -7.3% |
| Mar 12, 2026 | — | $-0.32 | — | -8.1% |
| Nov 10, 2025 | — | $-0.52 | — | +2.5% |
| Aug 12, 2025 | — | $-0.66 | — | +2.5% |
| May 12, 2025 | — | $-0.79 | — | +4.0% |
| Feb 12, 2025 | — | $-1.00 | — | -6.6% |
| Nov 12, 2024 | — | $-1.13 | — | +8.8% |
| Aug 13, 2024 | — | $-0.83 | — | +18.3% |
| May 9, 2024 | — | $-0.70 | — | -3.8% |
| Mar 21, 2024 | — | $-0.60 | — | +0.5% |
| Nov 7, 2023 | — | $-0.57 | — | +5.9% |
| Aug 7, 2023 | — | $-0.31 | — | -4.9% |
| May 15, 2023 | — | $-0.51 | — | -9.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.